Suita, Japan

Yoshiyuki Takei


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoshiyuki Takei: Innovator in Targeted Drug Delivery

Introduction

Yoshiyuki Takei is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of targeted drug delivery systems. His innovative approach focuses on enhancing the effectiveness of treatments by delivering foreign substances directly to specific organs.

Latest Patents

One of Yoshiyuki Takei's notable patents is titled "Carriers targettable to organ." This invention involves a carrier designed for delivering a foreign substance to a target organ. The carrier comprises a graft copolymer in which hyaluronic acid is grafted onto a polymer that forms the main chain. The main chain includes a part capable of binding to the foreign substance electrostatically. Additionally, it contains one or more monomer units with side chains that have amino or imino groups, which can couple to hyaluronic acid. This innovative carrier is particularly useful for delivering substances to the liver.

Career Highlights

Throughout his career, Yoshiyuki Takei has worked with notable companies in the pharmaceutical industry. He has been associated with Hisamitsu Pharmaceutical Company, Inc. and Rohto Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in drug delivery technologies.

Collaborations

Yoshiyuki Takei has collaborated with esteemed colleagues, including Atsushi Maruyama and Toshihiro Akaike. These partnerships have fostered innovation and development in the field of targeted therapies.

Conclusion

Yoshiyuki Takei's contributions to the field of targeted drug delivery highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence advancements in pharmaceutical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…